Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 428

1.

Advocating for a "Community to bench model" in the 21st century.

Tossas KY, Watson KS, Colditz GA, Thomas CR, Stewart JH, Winn RA.

EBioMedicine. 2020 Feb 26;53:102688. doi: 10.1016/j.ebiom.2020.102688. [Epub ahead of print] No abstract available.

2.

Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer.

Ko NY, Hong S, Winn RA, Calip GS.

JAMA Oncol. 2020 Jan 9. doi: 10.1001/jamaoncol.2019.5672. [Epub ahead of print]

PMID:
31917398
3.

Breaking the Cycle of Health Inequities: The Bioethics of Data.

Tossas-Milligan KY, Winn RA.

J Health Care Poor Underserved. 2019;30(4S):86-90. doi: 10.1353/hpu.2019.0119.

PMID:
31735722
4.

PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages.

Avasarala S, Wu PY, Khan SQ, Yanlin S, Van Scoyk M, Bao J, Di Lorenzo A, David O, Bedford MT, Gupta V, Winn RA, Bikkavilli RK.

Mol Cancer Res. 2020 Jan;18(1):166-178. doi: 10.1158/1541-7786.MCR-19-0204. Epub 2019 Oct 16.

5.

Engaging African American Men as Citizen Scientists to Validate a Prostate Cancer Biomarker: Work-in-Progress.

Watson KS, Henderson V, Murray M, Murphy AB, Levi JB, McDowell T, Holloway-Beth A, Gogana P, Dixon MA, Moore L, Hall I, Kimbrough A, Molina Y, Winn RA.

Prog Community Health Partnersh. 2019;13(5):103-112. doi: 10.1353/cpr.2019.0043.

6.

Building Cross-Institutional Collaborative Infrastructure and Processes: Early Lessons From the Chicago Cancer Health Equity Collaborative.

Simon MA, Fitzgibbon M, Ciecierski C, Cooper JM, Martinez E, Tom L, Kanoon J, Feinglass J, Warnecke R, Stuart M, Stern M, Filus L, Winn RA.

Prog Community Health Partnersh. 2019;13(5):5-13. doi: 10.1353/cpr.2019.0030.

7.

Community-Academic Partnerships: Approaches to Engagement.

Noel L, Phillips F, Tossas-Milligan K, Spear K, Vanderford NL, Winn RA, Vanderpool RC, Eckhardt SG.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:88-95. doi: 10.1200/EDBK_246229. Epub 2019 May 17. Review.

8.

Lung Cancer Screening and Epigenetics in African Americans: The Role of the Socioecological Framework.

Watson KS, Hulbert A, Henderson V, Chukwudozie IB, Aponte-Soto L, Lerner L, Martinez E, Kim S, Winn RA.

Front Oncol. 2019 Mar 12;9:87. doi: 10.3389/fonc.2019.00087. eCollection 2019.

9.

Society of Behavior Medicine (SBM) Urges Congress to Ensure Affordable Care Act Coverage of Prostate Cancer Screening Support Services for High-Risk Men.

Watson K, Buscemi J, Fitzgibbon M, Murray M, Murphy A, Abern M, Gann P, Levi JB, Stinson J, Diefenbach M, Winn RA.

Transl Behav Med. 2019 Mar 11. pii: ibz034. doi: 10.1093/tbm/ibz034. [Epub ahead of print]

PMID:
30855080
10.

Isolated unilateral vocal fold palsy: a rare complication of base of skull trauma.

Trautman J, Sarofim M, Kwok A, Creber N, Winn R.

ANZ J Surg. 2020 Jan;90(1-2):171-173. doi: 10.1111/ans.15043. Epub 2019 Mar 5. No abstract available.

PMID:
30836424
11.

Nontyphoidal Salmonella purulent pericarditis presenting with pericardial tamponade in a patient on infliximab therapy.

Saddler K, Castro-Lainez MT, Deliz-Aguirre R, Muñoz J, Aguilar Espinal JA, Sierra-Hoffman M, Chandna H, Howel A, Midturi J, Winn R.

IDCases. 2019 Feb 1;15:e00500. doi: 10.1016/j.idcr.2019.e00500. eCollection 2019.

12.

Acute cholecystitis and gallbladder perforation leading to massive haemoperitoneum in a patient taking rivaroxaban.

Kwok A, Chern TY, Winn R.

BMJ Case Rep. 2018 Oct 28;2018. pii: bcr-2018-226870. doi: 10.1136/bcr-2018-226870.

PMID:
30373899
13.

A rationale for combination ampicillin and daptomycin in renal transplant patients with enterococcal infective endocarditis.

Castro-Lainez MT, Sierra-Hoffman M, Valladares V, Tillman T, Iznaloa-Esquivel OA, Howell A, Fader R, Winn R, Jinadatha C.

IDCases. 2018 Oct 18;14:e00460. doi: 10.1016/j.idcr.2018.e00460. eCollection 2018.

14.

Rare case of delayed onset colitis due to immunotherapy for malignant melanoma.

Sarofim M, Winn R.

ANZ J Surg. 2019 Oct;89(10):E472-E473. doi: 10.1111/ans.14768. Epub 2018 Aug 22. No abstract available.

PMID:
30136350
15.

Management of Low-Risk Pulmonary Embolism.

Islam EA, Winn RE, Test V.

Clin Chest Med. 2018 Sep;39(3):561-568. doi: 10.1016/j.ccm.2018.04.013. Review.

PMID:
30122180
16.

Outcomes From a Minority-Based Lung Cancer Screening Program vs the National Lung Screening Trial.

Pasquinelli MM, Kovitz KL, Koshy M, Menchaca MG, Liu L, Winn R, Feldman LE.

JAMA Oncol. 2018 Sep 1;4(9):1291-1293. doi: 10.1001/jamaoncol.2018.2823. No abstract available.

17.

Lung cancer early detection and health disparities: the intersection of epigenetics and ethnicity.

Lerner L, Winn R, Hulbert A.

J Thorac Dis. 2018 Apr;10(4):2498-2507. doi: 10.21037/jtd.2018.04.07. Review.

18.

Is chloroquine neuromyotoxicity in a patient with refractory discoid lupus erythematosus potentiated by concomitant use of mepacrine?

Winn RT, Miller JAL, Meggitt SJ.

Clin Exp Dermatol. 2018 Dec;43(8):927-928. doi: 10.1111/ced.13666. Epub 2018 May 28. No abstract available.

PMID:
29808483
19.

Traditional culture methods fail to detect principle pathogens in necrotising soft tissue infection: a case report.

Zhao-Fleming HH, Barake SRS, Hand A, Wilkinson JE, Sanford N, Winn R, Dissanaike S.

J Wound Care. 2018 Apr 1;27(Sup4):S24-S28. doi: 10.12968/jowc.2018.27.Sup4.S24.

PMID:
29641341
20.

Mutilating male genital Crohn's without gastrointestinal involvement.

Winn RT, Brass D, Meggitt SJ.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):e355-e357. doi: 10.1111/jdv.14928. Epub 2018 Mar 26. No abstract available.

PMID:
29524254
21.

SBM recommends policy support to reduce smoking disparities for sexual and gender minorities.

Matthews PA, Blok AC, Lee JGL, Hitsman B, Sanchez-Johnsen L, Watson K, Breen E, Ruiz R, Scout, Simon MA, Fitzgibbon M, Hein LC, Winn R.

Transl Behav Med. 2018 Sep 8;8(5):692-695. doi: 10.1093/tbm/ibx017. Erratum in: Transl Behav Med. 2019 Mar 1;9(2):397.

22.

Wnt7a induces a unique phenotype of monocyte-derived macrophages with lower phagocytic capacity and differential expression of pro- and anti-inflammatory cytokines.

Wallace J, Lutgen V, Avasarala S, St Croix B, Winn RA, Al-Harthi L.

Immunology. 2018 Feb;153(2):203-213. doi: 10.1111/imm.12830. Epub 2017 Oct 12.

23.

A geographic information system-based method for estimating cancer rates in non-census defined geographical areas.

Freeman VL, Boylan EE, Pugach O, Mclafferty SL, Tossas-Milligan KY, Watson KS, Winn RA.

Cancer Causes Control. 2017 Oct;28(10):1095-1104. doi: 10.1007/s10552-017-0941-8. Epub 2017 Aug 20.

24.

Downregulation of PKCζ/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion.

Zhou Q, Dai J, Chen T, Dada LA, Zhang X, Zhang W, DeCamp MM, Winn RA, Sznajder JI, Zhou G.

Cell Signal. 2017 Oct;38:49-59. doi: 10.1016/j.cellsig.2017.06.016. Epub 2017 Jun 24.

25.

K-homology splicing regulatory protein (KSRP) promotes post-transcriptional destabilization of Spry4 transcripts in non-small cell lung cancer.

Bikkavilli RK, Zerayesus SA, Van Scoyk M, Wilson L, Wu PY, Baskaran A, Tang K, Raheem S, Samuelson BA, Reddy NM, Reddy SP, Cool CD, Kosmider B, Avasarala S, Winn RA.

J Biol Chem. 2017 May 5;292(18):7423-7434. doi: 10.1074/jbc.M116.757906. Epub 2017 Mar 8.

26.

Orthogonal lipid sensors identify transbilayer asymmetry of plasma membrane cholesterol.

Liu SL, Sheng R, Jung JH, Wang L, Stec E, O'Connor MJ, Song S, Bikkavilli RK, Winn RA, Lee D, Baek K, Ueda K, Levitan I, Kim KP, Cho W.

Nat Chem Biol. 2017 Mar;13(3):268-274. doi: 10.1038/nchembio.2268. Epub 2016 Dec 26.

27.

Subchronic perfluorooctanesulfonate (PFOS) exposure induces elevated mutant frequency in an in vivo λ transgenic medaka mutation assay.

Chen Y, Hu W, Huang C, Hua S, Wei Q, Bai C, Chen J, Norris MB, Winn R, Yang D, Dong Q.

Sci Rep. 2016 Dec 8;6:38466. doi: 10.1038/srep38466.

28.

Rationale and design of Mi-CARE: The mile square colorectal cancer screening, awareness and referral and education project.

Buscemi J, Miguel YS, Tussing-Humphreys L, Watts EA, Fitzgibbon ML, Watson K, Winn RA, Matthews KL, Molina Y.

Contemp Clin Trials. 2017 Jan;52:75-79. doi: 10.1016/j.cct.2016.11.009. Epub 2016 Nov 22.

29.

Society of Behavioral Medicine supports implementation of high quality lung cancer screening in high-risk populations.

Watson KS, Blok AC, Buscemi J, Molina Y, Fitzgibbon M, Simon MA, Williams L, Matthews K, Studts JL, Lillie SE, Ostroff JS, Carter-Harris L, Winn RA.

Transl Behav Med. 2016 Dec;6(4):669-671.

30.

Pseudomembranous colitis presenting as a mechanical large bowel obstruction.

Zhu KJ, Winn R.

ANZ J Surg. 2018 Sep;88(9):E685-E686. doi: 10.1111/ans.13679. Epub 2016 Jul 25. No abstract available.

PMID:
27457536
31.

Society of Behavioral Medicine (SBM) position statement: SBM supports the National Colorectal Cancer Roundtable's (NCCRT) call to action to reach 80 % colorectal cancer screening rates by 2018.

Becker EA, Buscemi J, Fitzgibbon ML, Watson K, Matthews KL, Winn RA; Society of Behavioral Medicine Health Policy Committee.

Transl Behav Med. 2016 Jun;6(2):306-8. doi: 10.1007/s13142-015-0364-6.

32.

Infective endocarditis caused by Klebsiella oxytoca in an intravenous drug user with cancer.

Mohamed A, Hall C, Hatch M, Ayan M, Winn R.

Proc (Bayl Univ Med Cent). 2016 Apr;29(2):181-2.

33.

Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells.

Lawrence JE, Steele CJ, Rovin RA, Belton RJ Jr, Winn RJ.

J Neurooncol. 2016 Mar;127(1):15-21. doi: 10.1007/s11060-015-2012-x. Epub 2015 Dec 7.

PMID:
26643803
34.

Buying In.

Winn RJ.

J Natl Compr Canc Netw. 2015 Nov;13(11):1301-2. No abstract available.

PMID:
26553761
35.

Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancer.

Bikkavilli RK, Avasarala S, Van Scoyk M, Arcaroli J, Brzezinski C, Zhang W, Edwards MG, Rathinam MK, Zhou T, Tauler J, Borowicz S, Lussier YA, Parr BA, Cool CD, Winn RA.

Oncogene. 2015 Oct 16;34(42):5406. doi: 10.1038/onc.2015.165. No abstract available.

PMID:
26473947
36.

Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1).

Sechler M, Borowicz S, Van Scoyk M, Avasarala S, Zerayesus S, Edwards MG, Kumar Karuppusamy Rathinam M, Zhao X, Wu PY, Tang K, Bikkavilli RK, Winn RA.

J Biol Chem. 2015 Jun 19;290(25):15610-20. doi: 10.1074/jbc.M114.631820. Epub 2015 Apr 29.

37.

PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer.

Avasarala S, Van Scoyk M, Karuppusamy Rathinam MK, Zerayesus S, Zhao X, Zhang W, Pergande MR, Borgia JA, DeGregori J, Port JD, Winn RA, Bikkavilli RK.

J Biol Chem. 2015 May 22;290(21):13479-89. doi: 10.1074/jbc.M114.636050. Epub 2015 Apr 6.

38.

Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancer.

Bikkavilli RK, Avasarala S, Van Scoyk M, Arcaroli J, Brzezinski C, Zhang W, Edwards MG, Rathinam MK, Zhou T, Tauler J, Borowicz S, Lussier YA, Parr BA, Cool CD, Winn RA.

Oncogene. 2015 Oct 16;34(42):5317-28. doi: 10.1038/onc.2015.2. Epub 2015 Mar 2. Erratum in: Oncogene. 2015 Oct 16;34(42):5406.

39.

The soft agar colony formation assay.

Borowicz S, Van Scoyk M, Avasarala S, Karuppusamy Rathinam MK, Tauler J, Bikkavilli RK, Winn RA.

J Vis Exp. 2014 Oct 27;(92):e51998. doi: 10.3791/51998.

40.

In vitro methylation assay to study protein arginine methylation.

Bikkavilli RK, Avasarala S, Van Scoyk M, Karuppusamy Rathinam MK, Tauler J, Borowicz S, Winn RA.

J Vis Exp. 2014 Oct 5;(92):e51997. doi: 10.3791/51997.

41.

'N-of-1-pathways' unveils personal deregulated mechanisms from a single pair of RNA-Seq samples: towards precision medicine.

Gardeux V, Achour I, Li J, Maienschein-Cline M, Li H, Pesce L, Parinandi G, Bahroos N, Winn R, Foster I, Garcia JG, Lussier YA.

J Am Med Inform Assoc. 2014 Nov-Dec;21(6):1015-25. doi: 10.1136/amiajnl-2013-002519. Epub 2014 Jun 12.

42.

Quantification of Protoporphyrin IX Accumulation in Glioblastoma Cells: A New Technique.

Lawrence JE, Patel AS, Rovin RA, Belton RJ Jr, Bammert CE, Steele CJ, Winn RJ.

ISRN Surg. 2014 Mar 4;2014:405360. doi: 10.1155/2014/405360. eCollection 2014.

43.

Complement plays a minimal role in Sm-p80-mediated protection against Schistosoma mansoni.

Karmakar S, Zhang W, Ahmad G, Alam MU, Winn R, Torben W, Le L, Tillery KA, Siddiqui AA.

Hum Vaccin Immunother. 2014;10(3):640-7. Epub 2013 Dec 27.

44.

The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma.

Parrish JK, Sechler M, Winn RA, Jedlicka P.

Oncogene. 2015 Jan 8;34(2):257-62. doi: 10.1038/onc.2013.541. Epub 2013 Dec 23.

45.

Heterotrimeric G-protein, Gα16, is a critical downstream effector of non-canonical Wnt signaling and a potent inhibitor of transformed cell growth in non small cell lung cancer.

Avasarala S, Bikkavilli RK, Van Scoyk M, Zhang W, Lapite A, Hostetter L, Byers JT, Heasley LE, Sohn JW, Winn RA.

PLoS One. 2013 Oct 18;8(10):e76895. doi: 10.1371/journal.pone.0076895. eCollection 2013.

46.

Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model.

Arcaroli JJ, Quackenbush KS, Purkey A, Powell RW, Pitts TM, Bagby S, Tan AC, Cross B, McPhillips K, Song EK, Tai WM, Winn RA, Bikkavilli K, Vanscoyk M, Eckhardt SG, Messersmith WA.

Br J Cancer. 2013 Aug 6;109(3):667-75. doi: 10.1038/bjc.2013.361. Epub 2013 Jul 18.

47.

hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression.

Avasarala S, Van Scoyk M, Wang J, Sechler M, Vandervest K, Brzezinski C, Weekes C, Edwards MG, Arcaroli J, Davis RE, Bikkavilli RK, Winn RA.

Biol Open. 2013 May 22;2(7):675-85. doi: 10.1242/bio.20134507. Print 2013 Jul 15.

48.

Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer.

Spreafico A, Tentler JJ, Pitts TM, Tan AC, Gregory MA, Arcaroli JJ, Klauck PJ, McManus MC, Hansen RJ, Kim J, Micel LN, Selby HM, Newton TP, McPhillips KL, Gustafson DL, Degregori JV, Messersmith WA, Winn RA, Eckhardt SG.

Clin Cancer Res. 2013 Aug 1;19(15):4149-62. doi: 10.1158/1078-0432.CCR-12-3140. Epub 2013 Jun 11.

49.

Non-small-cell lung cancer: molecular targeted therapy and personalized medicine - drug resistance, mechanisms, and strategies.

Sechler M, Cizmic AD, Avasarala S, Van Scoyk M, Brzezinski C, Kelley N, Bikkavilli RK, Winn RA.

Pharmgenomics Pers Med. 2013 Apr 4;6:25-36. doi: 10.2147/PGPM.S26058. Print 2013.

50.

Dishevelled3 is a novel arginine methyl transferase substrate.

Bikkavilli RK, Avasarala S, Vanscoyk M, Sechler M, Kelley N, Malbon CC, Winn RA.

Sci Rep. 2012;2:805. doi: 10.1038/srep00805. Epub 2012 Nov 13.

Supplemental Content

Support Center